Literature DB >> 3464353

Immunoregulating activity of tumor-associated macrophages.

G J Dougherty, W H McBride.   

Abstract

In this report, we examine the antigen nonspecific immunoregulating activity of macrophages isolated from the murine methylcholanthrene-induced fibrosarcoma FSA. These cells were shown to enhance the primary anti-CRBC PFC response of whole normal spleen cells in a dose-dependent fashion. This function was associated with a subpopulation of large Ia-negative macrophages and was mediated by a soluble macrophage-derived factor that appeared to act by stimulating the proliferation and/or differentiation of antigen-reactive T cells. The relationship of this factor to previously described monokines is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3464353     DOI: 10.1007/BF00205558

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  28 in total

1.  Induction of cytocidal macrophages after in vitro interactions between Listeria-immune T cells and macrophages--role of H-2.

Authors:  A G Farr; W J Wechter; J M Kiely; E R Unanue
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

Review 2.  Control of B-cell differentiation by macrophages.

Authors:  M K Hoffmann
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

3.  In situ Fc receptor-bearing cells in two murine tumors. II. Role in tumor immunity.

Authors:  J H Korn; J S Haskill; H T Holden; L A Radov; F L Ritter
Journal:  J Natl Cancer Inst       Date:  1978-06       Impact factor: 13.506

4.  Antigen-nonspecific helper factors in the antibody response.

Authors:  J J Farrar; M L Hilfiker
Journal:  Fed Proc       Date:  1982-02

5.  Antigen presentation: comments on its regulation and mechanism.

Authors:  E R Unanue; D I Beller; C Y Lu; P M Allen
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

6.  Tumor-specific T helper activity can be abrogated by two distinct suppressor cell mechanisms.

Authors:  S Howie; W H McBride
Journal:  Eur J Immunol       Date:  1982-08       Impact factor: 5.532

7.  Immunosuppression in mice bearing primary tumors.

Authors:  R B Whitney; B S Kelly; J G Levy
Journal:  Eur J Cancer       Date:  1978-06       Impact factor: 9.162

8.  The effects of interleukin 1 on human B cell activation and proliferation.

Authors:  R J Falkoff; A Muraguchi; J X Hong; J L Butler; C A Dinarello; A S Fauci
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

9.  The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen.

Authors:  P E Lipsky; P A Thompson; L J Rosenwasser; C A Dinarello
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

10.  Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.

Authors:  R N Moore; J J Oppenheim; J J Farrar; C S Carter; A Waheed; R K Shadduck
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

View more
  3 in total

Review 1.  Opportunities and challenges of radiotherapy for treating cancer.

Authors:  Dörthe Schaue; William H McBride
Journal:  Nat Rev Clin Oncol       Date:  2015-06-30       Impact factor: 66.675

Review 2.  Radiation and inflammation.

Authors:  Dörthe Schaue; Ewa D Micewicz; Josephine A Ratikan; Michael W Xie; Genhong Cheng; William H McBride
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

3.  Inhibitory effect of locally produced and exogenous interleukin-6 on tumor growth in vivo.

Authors:  G J Dougherty; J D Thacker; R S Lavey; A Belldegrun; W H McBride
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.